Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-07-31

FDA Approved: SIMVASTATIN — Supplemental Application (Accord Healthcare, Inc.)

View source ↗

Summary

The FDA approves Accord Healthcare, Inc.'s supplemental application for simvastatin (ANDA 078155), authorizing the continued marketing of this generic statin un…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SIMVASTATIN (SIMVASTATIN)

Snippet

SUPPL AP for SIMVASTATIN (SIMVASTATIN)